(Q35800117)

10 August 2017

0 references

1 reference

title

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review (English)

1 reference

10 August 2017

0 references

1 reference

1 reference

1 reference

Wulffelé MG

1

1 reference

10 August 2017

Kooy A

2

1 reference

10 August 2017

de Zeeuw D

3

1 reference

10 August 2017

Stehouwer CD

4

1 reference

10 August 2017

Gansevoort RT

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Journal of Internal Medicine

10 August 2017

1 reference

10 August 2017

256

1 reference

10 August 2017

1

1 reference

10 August 2017

1-14

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Dietary fat intake and prevention of cardiovascular disease: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Structure and function of TSPY, the Y-chromosome gene coding for the "testis-specific protein".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01328.X

10.1111/J.1365-2796.2004.01328.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference